BioSpace News Archive

Business

Insud Pharma and Fresenius Kabi combine efforts to accelerate the growth of mAbxience

Insud Pharma announced that it has entered into an agreement with Fresenius Kabi.

March 31, 2022
·
5 min read
Business

The Leapfrog Group Announces First-Ever National Ambulatory Surgery Center Advisory Committee

The Leapfrog Group today announced the members of its newly-formed Leapfrog Ambulatory Surgery Center (ASC) Advisory Committee.

March 31, 2022
·
3 min read
Lone Star Bio

Vizient Medical Device Tech Watch Provides Trends in Transcatheter Valve Replacement and a Model for Assessing New Technology in Musculoskeletal Care

In its latest Medical Device Tech Watch, Vizient, Inc. provides updated trends in patient quality outcomes for transcatheter valve replacement, including insights for complications and physician expertise.

March 31, 2022
·
3 min read
Drug Development

Clovis Oncology’s Rubraca® (Rucaparib) Significantly Improves Progression-Free Survival in First-line Maintenance Treatment in Women with Ovarian Cancer Regardless of Their Biomarker Status in Phase 3 ATHENA-MONO Trial

Clovis Oncology, Inc. announced positive top-line data from the monotherapy arm of the ATHENA trial demonstrating that Rubraca as maintenance treatment successfully achieved the primary endpoint of significantly improved investigator-assessed progression-free survival compared with placebo.

March 31, 2022
·
22 min read
Business

Nuvalent Appoints Anna Protopapas as Chair of Board of Directors

Nuvalent, Inc., a clinical stage biopharmaceutical company creating precisely targeted therapies for clinically proven kinase targets in cancer, announced the appointment of Anna Protopapas, President and Chief Executive Officer of Mersana Therapeutics, as Chair of its Board of Directors.

March 31, 2022
·
7 min read
Genetown

Amryt Supports World Lipodystrophy Day - March 31, 2022

DUBLIN, Ireland, and Boston MA, March 31, 2022, Amryt, a global, commercial-stage biopharmaceutical company focussed on acquiring, developing and commercializing novel treatments for rare diseases, is pleased to announce its support for World Lipodystrophy Day 2022 which takes place.

March 31, 2022
·
5 min read
Pharm Country

OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples

OraSure Technologies, Inc. announced that its’ Diversigen subsidiary has launched a new service to provide metatranscriptomic sequencing and analysis of gut microbiome samples.

March 31, 2022
·
7 min read
Policy

XORTX Files IND with US FDA

XORTX Therapeutics Inc., a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the filing of an investigational new drug application with the Unites States Food and Drug Administration.

March 31, 2022
·
6 min read
Business

Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the fourth quarter and year ended December 31, 2021 and provided key business updates.

March 31, 2022
·
12 min read
Business

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022

Renalytix plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, reported financial results for the quarter ended December 31, 2021.

March 31, 2022
·
80 min read